BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10614103)

  • 1. [Present status of PET images: clinical FDG PET in oncology].
    Inoue T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Nov; 59(13):737-44. PubMed ID: 10614103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders.
    Delbeke D; Patton JA; Martin WH; Sandler MP
    J Nucl Med; 1999 Jan; 40(1):110-7. PubMed ID: 9935066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical usefulness of FDG-PET in oncology].
    Sasaki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET.
    Zhang H; Tian M; Oriuchi N; Higuchi T; Tanada S; Endo K
    Br J Radiol; 2002 May; 75(893):409-16. PubMed ID: 12036833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
    Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
    Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
    Reske SN; Kotzerke J
    Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography imaging in oncology.
    Delbeke D; Martin WH
    Radiol Clin North Am; 2001 Sep; 39(5):883-917. PubMed ID: 11587060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear imaging of bone tumors: FDG-PET.
    Aoki J; Inoue T; Tomiyoshi K; Shinozaki T; Watanabe H; Takagishi K; Endo K
    Semin Musculoskelet Radiol; 2001 Jun; 5(2):183-7. PubMed ID: 11500164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of FDG PET and positron coincidence detection imaging using a dual-head gamma camera with 5/8-inch NaI(Tl) crystals in patients with suspected body malignancies.
    Boren EL; Delbeke D; Patton JA; Sandler MP
    Eur J Nucl Med; 1999 Apr; 26(4):379-87. PubMed ID: 10199944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
    Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
    Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of 18FDG positron emission tomography in detection and follow-up of digestive cancers.
    Paulus P; Hustinx R; Daenen F; Jacquet N; Rigo P
    Acta Gastroenterol Belg; 1997; 60(4):278-80. PubMed ID: 9529672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical application of FDG-PET for cancer diagnosis].
    Nakamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Jul; 63(6):285-93. PubMed ID: 12934545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New functional imaging technique "positron emission tomography"].
    Tamaki N
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):101-4. PubMed ID: 9612703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18-Fluorodeoxyglucose imaging in oncology.
    Harolds JA
    J Okla State Med Assoc; 1999 Sep; 92(9):457-61. PubMed ID: 10504797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].
    Comans EF; Hoekstra OS; Hoekman K; van der Hoeven JJ; Golding RP; Teule GJ
    Ned Tijdschr Geneeskd; 2000 Aug; 144(32):1520-8. PubMed ID: 10949634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
    Yutani K; Tatsumi M; Shiba E; Kusuoka H; Nishimura T
    J Nucl Med; 1999 Jun; 40(6):1003-8. PubMed ID: 10452318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET for evaluating musculoskeletal tumors: a review.
    Aoki J; Endo K; Watanabe H; Shinozaki T; Yanagawa T; Ahmed AR; Takagishi K
    J Orthop Sci; 2003; 8(3):435-41. PubMed ID: 12768492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18-FDG positron imaging in oncological patients: gamma camera coincidence detection versus dedicated PET.
    Zimny M; Kaiser HJ; Cremerius U; Sabri O; Schreckenberger M; Reinartz P; Büll U
    Nuklearmedizin; 1999; 38(4):108-14. PubMed ID: 10392375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET FDG studies in oncology.
    Hawkins RA; Hoh CK
    Nucl Med Biol; 1994 Jul; 21(5):739-47. PubMed ID: 9241650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.